ARTICLE | Company News
Cancer Research Technology Ltd. (CRT), Cancer Research U.K., The Institute of Cancer Research cancer news
April 29, 2013 7:00 AM UTC
The CRT Pioneer Fund announced that its first investment will be used to advance TTK protein kinase (TTK; MPS1) inhibitors into clinical testing to treat cancer. The compounds originate from Cancer ...